Global Pediatric Surgical Technology and Education Project, Inc. – Trademark Portfolio
Entity Type: 03
Global Pediatric Surgical Technology and Education Project, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FRYKMAN - KIMBLE STIMULATOR. The owner is based in Irvine, CA.
3972 Barranca Parkway, Suite J293
Irvine, CA 92606
Showing of trademarks Trademarks
Trademark Classifications
Global Pediatric Surgical Technology and Education Project, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Global Pediatric Surgical Technology and Education Project, Inc. have?
Global Pediatric Surgical Technology and Education Project, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Global Pediatric Surgical Technology and Education Project, Inc. file in?
Global Pediatric Surgical Technology and Education Project, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Global Pediatric Surgical Technology and Education Project, Inc.'s most well-known trademarks?
Global Pediatric Surgical Technology and Education Project, Inc.'s registered trademark portfolio includes well-known marks such as FRYKMAN - KIMBLE STIMULATOR. These are among 1 currently registered trademark in the portfolio.
What is Global Pediatric Surgical Technology and Education Project, Inc.'s trademark registration success rate?
Global Pediatric Surgical Technology and Education Project, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.